Skip to main content
. Author manuscript; available in PMC: 2022 Jan 20.
Published in final edited form as: Int J Cancer. 2020 Jul 16;147(11):3160–3167. doi: 10.1002/ijc.33119

TABLE 1.

Demographics and clinical characteristics of the study cohort

Patients with normal QTc Patients with long QTc P valuea
Number 410 208
Male gender 251 (61.2%) 136 (65.3%) .312
Age (years) 59.2 ± 12.3 60.1 ± 13.4 .028
Body mass index (kg/m2) 28.8 ± 6.5 32.8 ± 8.6 <.001
Hypertension 253 (61.7%) 155 (74.5%) .001
Diabetes mellitus 105 (25.6%) 96 (46.2%) <.001
Hyperlipidemia 192 (46.8%) 130 (62.5%) <.001
Heart failure 48 (11.7%) 61 (29.3%) <.001
Coronary artery disease 139 (33.9%) 81 (38.9%) .216
Tumor type
 RCC 190 (46.3%) 71 (34.1%) .003
 CML 112 (27.3%) 63 (30.3%) .438
 AML 7 (1.7%) 11 (5.3%) .124
 ALL 20 (4.9%) 21 (10.1%) .014
 Thyroid 31 (7.6%) 22 (10.6%) .206
 GIST 19 (4.6%) 9 (4.3%) .862
 Lung 31 (7.6%) 11 (5.3%) .288

Abbreviations: ALL, acute lymphocytic leukemia; AML, acute myeloid leukemia; GIST, gastrointestinal stromal tumor; CML, chronic myeloid leukemia; RCC, renal cell carcinoma.

a

P value for comparisons between all patients with normal QTc vs all patients with long QTc interval.